BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7518983)

  • 1. Morphometric quantitation of stroma in human benign prostatic hyperplasia.
    Deering RE; Bigler SA; King J; Choongkittaworn M; Aramburu E; Brawer MK
    Urology; 1994 Jul; 44(1):64-70. PubMed ID: 7518983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is one single prostate biopsy helpful for choosing a medical treatment of benign prostatic hyperplasia? A quantitative computerized morphometric study.
    Zlota Ar; Sattar AA; Wespes E; Noel JC; Schulman CC
    Urology; 1996 Mar; 47(3):329-34. PubMed ID: 8633397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between the prostatic tissue components and natural history of benign prostatic hyperplasia.
    Matsuda T; Fujime M; Suda K
    Anal Quant Cytol Histol; 2006 Jun; 28(3):121-4. PubMed ID: 16786720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stromal and acinar components of the transition zone in normal and hyperplastic human prostate.
    Chagas MA; Babinski MA; Costa WS; Sampaio FJ
    BJU Int; 2002 May; 89(7):699-702. PubMed ID: 11966627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percentage area density of epithelial and mesenchymal components in benign prostatic hyperplasia: comparison of results between single biopsy, multiple biopsies and multiple tissue specimens.
    Robert M; Costa P; Bressolle F; Mottet N; Navratil H
    Br J Urol; 1995 Mar; 75(3):317-24. PubMed ID: 7537601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrastructural and biophysical studies on protein conformations of epithelium and stroma in benign prostatic hyperplasia before and after transurethral resection of the prostate.
    Hsu HS; Lin SY; Li MJ; Liang RC
    Ultrastruct Pathol; 2002; 26(3):137-41. PubMed ID: 12184371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relative proportion of stromal and epithelial hyperplasia is related to the development of symptomatic benign prostate hyperplasia.
    Shapiro E; Becich MJ; Hartanto V; Lepor H
    J Urol; 1992 May; 147(5):1293-7. PubMed ID: 1373778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible mechanisms of action of transurethral needle ablation of the prostate on benign prostatic hyperplasia symptoms: a neurohistochemical study.
    Zlotta AR; Raviv G; Peny MO; Noel JC; Haot J; Schulman CC
    J Urol; 1997 Mar; 157(3):894-9. PubMed ID: 9072594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between urodynamic type of obstruction and histological component of the prostate in patients with benign prostatic hyperplasia.
    Ichiyanagi O; Sasagawa I; Ishigooka M; Suzuki Y; Nakada T
    Eur Urol; 1999 Sep; 36(3):203-6. PubMed ID: 10450003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphometry of the prostate: I. Distribution of tissue components in hyperplastic glands.
    Marks LS; Treiger B; Dorey FJ; Fu YS; deKernion JB
    Urology; 1994 Oct; 44(4):486-92. PubMed ID: 7524234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stromal cells of the human prostate: initial isolation and characterization.
    Kassen A; Sutkowski DM; Ahn H; Sensibar JA; Kozlowski JM; Lee C
    Prostate; 1996 Feb; 28(2):89-97. PubMed ID: 8604397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myosin heavy chain gene expression in normal and hyperplastic human prostate tissue.
    Lin VK; Wang D; Lee IL; Vasquez D; Fagelson JE; McConnell JD
    Prostate; 2000 Aug; 44(3):193-203. PubMed ID: 10906735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative morphometric study of bladder detrusor between patients with benign prostatic hyperplasia and controls.
    Inui E; Ochiai A; Naya Y; Ukimura O; Kojima M
    J Urol; 1999 Mar; 161(3):827-30. PubMed ID: 10022694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphometric analysis of symptomatic benign prostatic hyperplasia with and without bladder outlet obstruction.
    Ichiyanagi O; Sasagawa I; Ishigooka M; Suzuki Y; Nakada T
    Urol Res; 2000 Jan; 28(1):29-32. PubMed ID: 10732692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should the diagnosis of benign prostatic hyperplasia be made on prostate needle biopsy?
    Viglione MP; Potter S; Partin AW; Lesniak MS; Epstein JI
    Hum Pathol; 2002 Aug; 33(8):796-800. PubMed ID: 12203211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostatic histology in secondary transurethral resection of the prostate.
    Jønler M; Bruskewitz RC
    J Urol; 1995 Jul; 154(1):119-22. PubMed ID: 7539855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the mechanism of discrepant nuclear morphometric results comparing preoperative biopsy and prostatectomy specimens.
    Kanamaru H; Zhang YH; Takahashi M; Nakamura N; Ishida H; Akino H; Muranaka K; Okada K
    Urology; 2000 Aug; 56(2):342-5. PubMed ID: 10925120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative proportions of tissue components in the prostate: are they related to the development of symptomatic BPH in Korean men?
    Byun SS; Jeong H; Jo MK; Lee E
    Urology; 2005 Sep; 66(3):593-6. PubMed ID: 16140084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated epithelial expression of interleukin-8 correlates with myofibroblast reactive stroma in benign prostatic hyperplasia.
    Schauer IG; Ressler SJ; Tuxhorn JA; Dang TD; Rowley DR
    Urology; 2008 Jul; 72(1):205-13. PubMed ID: 18314176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stromal nodules in benign prostatic hyperplasia.
    Bierhoff E; Vogel J; Benz M; Giefer T; Wernert N; Pfeifer U
    Eur Urol; 1996; 29(3):345-54. PubMed ID: 8740022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.